US Stock MarketDetailed Quotes

Clearside Biomedical (CLSDQ)

Watchlist
  • 0.3100
  • -0.0302-8.88%
15min DelayClose Jun 5 10:52 ET
1.62MMarket Cap-0.06P/E (TTM)

About Clearside Biomedical Company

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Company Profile

SymbolCLSDQ
Company NameClearside Biomedical
ISINUS1850632035
Founded2011
CEODr. George Lasezkay, J.D.,Pharm.D.
MarketPink Market
Employees32
Fiscal Year Ends12-31
Address900 North Point Parkway,Suite 200
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30005
Phone1-678-270-3631

Company Executives

  • Name
  • Position
  • Salary
  • Clay B. Thorp
  • Chairman of the Board
  • --
  • Dr. George Lasezkay, J.D.,Pharm.D.
  • Director
  • --
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Over the weekend, Iran launched missiles at Israel again—its first such strike in two months following the April 8 ceasefire between the U.S Show More